| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant methylation of FBN2 in human non-small cell lung cancer
|
Chen, Hong
|
|
2005
|
50 |
1 |
p. 43-49
7 p.
|
artikel
|
| 2 |
Acquisition of fluorescence and reflectance spectra during routine bronchoscopy examinations using the ClearVu Elite™ device: Pilot study
|
Tercelj, Marjeta
|
|
2005
|
50 |
1 |
p. 35-42
8 p.
|
artikel
|
| 3 |
Aims and Scopes
|
|
|
2005
|
50 |
1 |
p. v-
1 p.
|
artikel
|
| 4 |
A lack of prognostic significance regarding ΔNp63 immunoreactivity in lung cancer
|
Iwata, Teruo
|
|
2005
|
50 |
1 |
p. 67-73
7 p.
|
artikel
|
| 5 |
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma
|
Berghmans, T.
|
|
2005
|
50 |
1 |
p. 75-82
8 p.
|
artikel
|
| 6 |
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)
|
Scagliotti, Giorgio V.
|
|
2005
|
50 |
1 |
p. 91-96
6 p.
|
artikel
|
| 7 |
Benefit in lung function improvement and side-effect profile of long-term responders: An analysis of 14 NSCLC patients treated for at least 9 months with gefitinib
|
Reck, Martin
|
|
2005
|
50 |
1 |
p. 107-114
8 p.
|
artikel
|
| 8 |
Calendar of Events
|
|
|
2005
|
50 |
1 |
p. xi-
1 p.
|
artikel
|
| 9 |
Consensus on medical treatment of non-small-cell lung cancer—update 2004
|
Zielinski, C.C.
|
|
2005
|
50 |
1 |
p. 129-137
9 p.
|
artikel
|
| 10 |
Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: A multicentre phase II study
|
Ziotopoulos, Panagiotis
|
|
2005
|
50 |
1 |
p. 115-122
8 p.
|
artikel
|
| 11 |
Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells
|
Kitazaki, Takeshi
|
|
2005
|
50 |
1 |
p. 19-24
6 p.
|
artikel
|
| 12 |
Instruction to authors
|
|
|
2005
|
50 |
1 |
p. 139-141
3 p.
|
artikel
|
| 13 |
Limited efficacy of imatinib mesylate in malignant mesothelioma: A phase II trial
|
Mathy, Alexandre
|
|
2005
|
50 |
1 |
p. 83-86
4 p.
|
artikel
|
| 14 |
Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter
|
van den Toorn, Leon M.
|
|
2005
|
50 |
1 |
p. 123-127
5 p.
|
artikel
|
| 15 |
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer
|
Rosell, Rafael
|
|
2005
|
50 |
1 |
p. 25-33
9 p.
|
artikel
|
| 16 |
Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung
|
Yoshida, Yukihiro
|
|
2005
|
50 |
1 |
p. 1-8
8 p.
|
artikel
|
| 17 |
Phase II trials in mesothelioma: An increasing challenge
|
Nowak, Anna K.
|
|
2005
|
50 |
1 |
p. 87-90
4 p.
|
artikel
|
| 18 |
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)
|
Laack, Eckart
|
|
2005
|
50 |
1 |
p. 51-58
8 p.
|
artikel
|
| 19 |
The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells
|
Hermann, Thomas W.
|
|
2005
|
50 |
1 |
p. 9-18
10 p.
|
artikel
|
| 20 |
Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: A Phase I/II study with 5 years’ follow-up
|
Brunsvig, Paal F.
|
|
2005
|
50 |
1 |
p. 97-105
9 p.
|
artikel
|
| 21 |
World Health Organization histologic classification: An independent prognostic factor in resected thymomas
|
Rena, Ottavio
|
|
2005
|
50 |
1 |
p. 59-66
8 p.
|
artikel
|
Tijdschrift beschrijving